← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

M

$ Value

$0

Shares

11,695

Price

$0

Filed

Aug 4

Insider

Name

Duarte Ira

Title

EVP, Chief Financial Officer

CIK

0001488864

Roles

Officer

Transaction Details

Transaction Date

2025-07-31

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

163,721

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock. | The number of restricted stock units disclosed on the Reporting Person's Form 4 filed on April 22, 2025, May 2, 2025 and June 17 , 2025 ("Affected Form 4 Filings") were erroneously disclosed as an acquisition in Column 5(A) when it should have been disclosed as a disposition in Column 5(D). All other information in the Affected Form 4 Filings is correct. | The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Filing Info

Accession No.

0000950170-25-102158

Form Type

4

Issuer CIK

0000818033

Duarte Ira's History

Date Ticker Type Value
2026-04-19 HRTX M
2026-04-19 HRTX M $0
2026-01-31 HRTX M
2026-01-31 HRTX M $0
2026-01-30 HRTX A $0
2026-01-30 HRTX A $0
2026-01-19 HRTX M
2026-01-19 HRTX M $0
2025-10-31 HRTX M
2025-10-31 HRTX M $0

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Dissanaike Sharmila 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30